A tangent: the UK has some of the best monitoring implemented and sees antibodies in about 95% of its population. That said, reinfection rate as of June 2021 (roughly pre-Delta) was 0.4% over that population cohort.
https://www.gov.uk/government/news/new-national-surveillance...